Market Place
Sourcing Support
IR-MED CEO Letter to Shareholders: Expanding Platform, New Data
18 Mar 2025 //
GLOBENEWSWIRE
Methodist Healthcare Adopts IR-MED`s PressureSafe Device
10 Sep 2024 //
GLOBENEWSWIRE
IR-MED Appoints Ran Ziskind As Chief Executive Officer
28 Aug 2024 //
GLOBENEWSWIRE
IR-MED Wins Prestigious Netty Award for Best Up-and-Coming Health Tech Company
21 Aug 2024 //
GLOBENEWSWIRE
IR-MED Receives $500K Grant For Diabetic Foot Ulcer Detection Technology
15 Jul 2024 //
GLOBENEWSWIRE
IR-MED`s PressureSafe Reduced Pressure Injuries 50% In Clalit Study
22 May 2024 //
GLOBENEWSWIRE
IR-MED`s PressureSafe Receives FDA Listing
05 Apr 2024 //
GLOBENEWSWIRE
IR-MED Reports 92% Efficacy for PressureSafe
20 Feb 2024 //
GLOBENEWSWIRE
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries
13 Feb 2024 //
GLOBENEWSWIRE
IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer
21 Dec 2023 //
GLOBENEWSWIRE
IR-MED Granted Patent in Israel for its AI-Driven Platform Technology
07 Dec 2023 //
GLOBENEWSWIRE
IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as CEO
04 Oct 2023 //
GLOBENEWSWIRE
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio
26 Sep 2023 //
GLOBENEWSWIRE
IR-MED Chairman & Interim CEO Issues Letter to Shareholders
21 Aug 2023 //
GLOBENEWSWIRE
IR-MED Honors Juneteenth with Commitment to Healthcare Equality
12 Jun 2023 //
GLOBENEWSWIRE
IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board
07 Jun 2023 //
GLOBENEWSWIRE
IR-Med to present at National Pressure Injury Advisory Panel 2023
14 Mar 2023 //
GLOBENEWSWIRE
IR-Med Signs Agreement To Expand Its Pressuresafe Device Usability Study
14 Feb 2023 //
GLOBENEWSWIRE
IR-MED Names Moshe Gerber as New CEO
10 May 2022 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.